Reports for POTASSIUM CHLORIDE
Ingredient
POTASSIUM CHLORIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NXSTAGE PUREFLOW SOLUTION RFP-209-CAN | 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G | SOLUTION | Resolved | 2019-02-15 | 2019-03-12 | 76025 |
MOVIPREP | 4.7G 5.9G 1.015G 2.691G 7.5G 100G | POWDER FOR SOLUTION | Resolved | 2022-08-10 | 2022-10-01 | 166431 |
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE | 200mEq | SOLUTION | Resolved | 2019-10-10 | 2023-01-20 | 96052 |
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE | 200mEq | SOLUTION | Resolved | 2023-03-31 | 2023-05-24 | 188487 |
PLASMA-LYTE A INJECTION | 368MG 30MG 37MG 526MG 502MG | SOLUTION | Resolved | 2019-02-15 | 2019-03-19 | 76031 |
PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-09-01 | 122375 |
PLASMA-LYTE A INJECTION | 526MG 368MG 502MG 37MG 30MG | SOLUTION | Resolved | 2020-08-17 | 2020-08-18 | 122377 |
BI-PEGLYTE | 0.76G 1.46G 1.69G 5.74G 59.55G 5MG | POWDER FOR SOLUTION KIT TABLET (DELAYED-RELEASE) | Resolved | 2021-11-03 | 2021-12-15 | 148737 |
LACTATED RINGER'S AND 5% DEXTROSE | 3.1MG 50.0MG 0.2MG 0.3MG 6.0MG | SOLUTION | Resolved | 2017-09-28 | 2018-01-01 | 23829 |
POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE | 0.15G 0.9G | SOLUTION | Resolved | 2019-06-21 | 2020-02-20 | 87215 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE | 0.9G 0.3G 5G | SOLUTION | To be discontinued | 2021-11-02 | 2021-11-02 | 148674 |
NORMOSOL-R | 0.502G 0.222G 0.526G 0.014G 0.037G | SOLUTION | To be discontinued | 2023-10-02 | 2023-10-27 | 205624 |
NORMOSOL-R | 0.502G 0.222G 0.526G 0.014G 0.037G | SOLUTION | To be discontinued | 2023-10-26 | 2023-10-27 | 208273 |